HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Amazon Flexes E-Commerce Heft By Imposing Quality-Control Requirements For Supplements

Executive Summary

Amazon requires firms selling supplements on its site in the US to demonstrate their products comply with FDA regulations for labeling and GMPs. Marketers that don’t submit documentation face removal of their products from the site.

You may also be interested in...



ED-Spiked Supplements Sold On Amazon Fill US FDA’s Recall Plate

Announcements for seven adulterated male sexual enhancement products were published across the work week, concluding with NANA Collection LLC’s products branded PremierZen Platinum 5000, found with undisclosed tadalafil, and Triple SupremeZen 3500, found to contain tadalafil and sildenafil, on 2 April.

More ED-Spiked Supplements Sold On Amazon Recalled Following US FDA Tests

US FDA published announcement by two firms recalling products they sold under the brand Thumbs Up 7 and that were found in FDA tests to contain undeclared sildenafil and tadalafil.

US FDA Concern Rekindled After Finding ED-Spiked Supplements Sold On Amazon

NJ firms S&B Shopper and Namoo Enterprise recall products after FDA tests found undisclosed erectile dysfunction drugs sildenafil and tadalafil. FDA officials Imperial Extreme 2000 and Namoo’s PremierZen Black 5000 capsules on Amazon.

Related Content

Topics

UsernamePublicRestriction

Register

RS150877

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel